Predict your next investment

HEALTHCARE | Medical Equipment & Supplies

See what CB Insights has to offer

Founded Year


Total Raised



Provider of non-invasive diagnostic tools. The company provides breath testing devices based on metabolites and stable isotopes designed for use in the diagnosis of Helicobacter pylori infection, gastric emptying rate, and pancreatic insufficiency. The company also offers nuclear-magnetic-resonance (NMR) spectroscopy and imaging services for the treatment of a range of metabolic disorders and malignant conditions.

INFAI Headquarter Location

Gottfried-Hagen-Strasse 60-62

Cologne, 51105,


49 22 188 04 44 0

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.